Metabonomic analysis of hepatitis B virus-induced liver failure： identification of potential diagnostic biomarkers by fuzzy support vector machine

Hepatitis B virus （HBV）-induced liver failure is an emergent liver disease leading to high mortality. The severity of liver failure may be reflected by the profile of some metabolites. This study assessed the potential of using metabolites as biomarkers for liver failure by identifying metabolites with good discriminative performance for its phenotype. The serum samples from 24 HBV-indueed liver failure patients and 23 healthy volunteers were collected and analyzed by gas chromatography-mass spectrometry （GC-MS） to generate metabolite profiles. The 24 patients were further grouped into two classes according to the severity of liver failure. Twenty-five eommensal peaks in all metabolite profiles were extracted, and the relative area values of these peaks were used as features for each sample. Three algorithms, F-test, k-nearest neighbor （KNN） and fuzzy support vector machine （FSVM） combined with exhaustive search （ES）, were employed to identify a subset of metabolites （biomarkers） that best predict liver failure. Based on the achieved experimental dataset, 93.62% predictive accuracy by 6 features was selected with FSVM-ES and three key metabolites, glyeerie acid, cis-aeonitie acid and citric acid, are identified as potential diagnostic biomarkers.     

Functions of fatty acid binding proteins

Summary Cytosolic fatty acid binding proteins (FABP) belong to a gene family of which eight members have been conclusively identified. These 14–15 kDa proteins are abundantly expressed in a highly tissue-specific manner. Although the functions of the cytosolic FABP are not clearly established, they appear to enhance the transfer of long-chain fatty acids between artificial and native lipid membranes, and also to have a stimulatory effect on a number of enzymes of fatty acid metabolism in vitro. These findings, as well as the tissue expression, ligand binding properties, ontogeny and regulation of these proteins provide a considerable body of indirect evidence supporting a broad role for the FABP in the intracellular transport and metabolism of long-chain fatty acids. The available data also support the existence of structure- and tissue-specific specialization of function among different members of the FABP gene family. Moreover, FABP may also have a possible role in the modulation of cell growth and proliferation, possibly by virtue of their affinity for ligands such as prostaglandins, leukotrienes and fatty acids, which are known to influence cell growth activity. FABP structurally unrelated to the cytosolic gene family have also been identified in the plasma membranes of several tissues (FABP_pm). These proteins have not been fully characterized to date, but strong evidence suggests that they function in the transport of long-chain fatty acids across the plasma membrane.     

诺维本联合MMC、PDD治疗肺部肿瘤32例疗效观察

目的:探讨诺维本(NVB)联合MMC、PDD治疗非小细胞肺癌的疗效.方法:第1 d,8 d,15 d静注NVB40 mg;并于第1 d静注MMC 10 mg,第15 d静注PDD 60 mg;21 d为一疗程.以WHO(1981)统一评定标准评价疗效及毒副作用.结果:总有效率(PR+CR)53.1%,其中初治59.1%,复治40.0%;鳞癌62.5%,腺癌52.6%,腺鳞癌40.0%,Ⅲa期66.7%,Ⅲb期66.7%,Ⅳ期35.7%.毒副反应主要表现为白细胞下降.结论:NVB与MMC、PDD有协同作用,可以提高治疗肺部肿瘤的疗效,且毒副反应可以耐受,有推广应用价值.     

乙酰肝素酶与甲状腺乳头状癌淋巴结转移的相关性研究

【目的】通过研究乙酰肝素酶(HPA)含量与微淋巴管密度的关系,探讨HPA在甲状腺乳头状癌淋巴结转移中的作用。【方法】采用Envision免疫组织化学两步法检测150例甲状腺乳头状癌和200例结节性甲状腺肿患者乙酰肝素酶、D2-40的表达情况,计算乙酰肝素酶平均光密度值与D2-40阳性标记的微淋巴管密度,分析乙酰肝素酶含量与微淋巴管密度间的关系,同时与结节性甲状腺肿患者微淋巴管密度和乙酰肝素酶含量分别进行比较。【结果】甲状腺乳头状癌患者微淋巴管密度和乙酰肝素酶含量明显高于结节性甲状腺肿患者(P0.01),癌组织乙酰肝素酶含量与微淋巴管密度呈正相关关系(P0.01)。【结论】甲状腺乳头状癌患者乙酰肝素酶与微淋巴管形成有密切关系,乙酰肝素酶可作为其临床疗效判断和新药研发的参考指标。     

鼻咽癌近距离放疗仿真

近距离放疗是鼻咽癌治疗的主要手段之一.其计算机仿真可帮助医生制定详细的放疗方案,对鼻咽癌精确放疗具有显著意义.一个完整的鼻咽癌近距离放疗仿真的方案被提出.首先,对CT图像进行分割,重建三维组织模型.然后,设计了基于Ta-chih Lee细化算法的鼻咽腔放疗源虚拟输送路径.最后,对125I柱状放射源放射剂量分布进行了蒙特卡罗仿真.初步实现了鼻咽癌近距离放疗的计算机仿真.     

新疆维吾尔族妇女宫颈癌中HPV16感染和p53蛋白表达的相关性研究

采用半巢式PCR法检测 80例新疆维吾尔族宫颈癌及 3 4例正常宫颈组织中HPV16DNA ,采用免疫组化法检测p5 3蛋白 ,分析其与宫颈癌发生的相关性 ,探讨HPV16感染和p5 3蛋白表达在新疆维吾尔族妇女宫颈癌发生中的作用。结果显示 :HPV16检出率在宫颈癌中为 80 .0 % ,与对照组 8.8%相比 ,存在显著性差异 ( χ2 =4 9.88,P <0 .0 0 5 ) ;宫颈癌组织中p5 3蛋白表达阳性率为 6 2 .5 % ,也明显高于对照组 ,P <0 .0 0 5 ;p5 3蛋白表达与HPV16感染在统计学上无相关 ( χ2 =0 .0 ,P >0 .0 5 )。表明 :HPV16感染与新疆维吾尔族妇女宫颈癌发生密切相关 ;HPV16感染的宫颈癌组织中p5 3蛋白表达有升高趋势     

大鼠再生肝8种细胞的PPARγ信号通路相关基因转录谱预示脂类代谢活动

为了解大鼠肝再生中肝细胞、胆管上皮细胞、卵圆细胞、星形细胞、窦内皮细胞、库普弗细胞、陷窝细胞、树突状细胞等8种肝脏细胞的PPARγ信号通路相关基因转录谱及其预示的脂类代谢活动,按本卷2期张丽君[1]等方法分离大鼠再生肝8种细胞,检测它们的PPARγ信号通路基因表达谱,分析其预示的生理活动.结果表明,41个PPARγ信号通路相关基因在大鼠肝再生中发生了有意义的表达变化,其中上调、下调和上/下调的基因为9、9、23个,呈现15种表达相关性.相应细胞的基因数为10、6和1,10、12和2,7、7和0,16、8和3,18、7和1,10、6和1,11、20和0,13、9和4.它们的转录谱预示,胆管上皮细胞和星形细胞的脂肪合成、星形细胞和树突状细胞的胆固醇代谢、8种肝脏细胞的脂肪酸运输和脂肪细胞分化、星形细胞、窦内皮细胞和树突状细胞的脂肪酸氧化和糖异生、胆管上皮细胞和树突状细胞的能量代谢增强.上述结果表明,PPARγ信号通路与大鼠肝再生密切相关.     

胃癌组织中Survivin的表达与细胞凋亡的关系研究

目的通过检测Survivin及相关指标在人胃癌组织中的表达及其与临床病理参数的关系,探讨Survivin对胃癌组织细胞凋亡的作用.方法采用免疫组织化学SP方法检测60例胃癌组织,7例正常胃黏膜组织Survivin,p53的表达水平.结果Survivin,p53蛋白阳性率分别为56.7%,65%;Survivin蛋白的表达与患者性别、年龄、肿瘤直径、TNM分期均无明显相关性(P>0.05),与组织学分级、淋巴结转移具有相关性(P<0.05);Survivin的表达与p53呈正相关.结论Survivin的过表达与胃癌的发生、发展及预后密切相关.Survivin具有抑制凋亡的作用.     

肥胖,高脂血症性脂肪性肝炎模型的建立

为建立大鼠肥胖、高脂血症性脂肪性肝炎（ＮＡＳＨ）的动物模型。取雄性ＳＤ大鼠１９只,随机人分为模型组（ｎ＝１０）和正常组（ｎ＝９）。模型组喂高脂饮食,即普通饲料基础上加１０％猪油,２％胆固醇。正常组喂普通饲料。观察一般情况血清肝功能、血脂,并行病理学检查。模型组体重、肝指数、血清总胆固醇、游高脂肪酸及转氨酶均显著高于正常组;病理学均出现弥漫性肝细胞脂肪变性,且１００％存在小叶内炎症,８０％出现汇管区     

基于疏肝解郁功效的逍遥散寒苦肝和温辛肝性效关系研究

为探讨逍遥散中疏肝解郁中药的寒温差异与其功效的内在联系,通过数据库检索获取寒苦肝和温辛肝药性的主要有效成分及作用靶点,基于STRING平台构建蛋白质-蛋白质相互作用网络,采用Metascape对识别出的药性组合蛋白质-蛋白质相互作用网络进行京都基因与基因组百科全书通路注释和统计分析。结果表明:逍遥散中归肝经药性主要通过HTR2B等靶点参与神经递质、信号通路、内分泌发挥疏肝解郁的功效特点;逍遥散中寒苦药性主要通过CREBRF等靶点参与能量代谢、炎症反应发挥疏肝解郁的功效特点;逍遥散中温辛组合药性主要通过ADCY5等靶点参与炎症反应神经营养、氨基酸代谢发挥疏肝解郁的功效特点。该研究从分子网络水平阐释了逍遥散中归肝经药性的共性特征和寒苦药性、温辛药性的特异性特征,为逍遥散的药性与功效的内在联系研究提供了新思路和新方法。